Liquid biopsy biomarker VS tumour biopsy: Study reveals which one is more reliable for lung cancer diagnosis - Times Now

Mount Sinai researchers have proven that a simple blood test called a liquid biopsy can be a stronger predictor of whether cancer immunotherapy will work for a patient with lung cancer than an invasive tumour biopsy technique.

The liquid biopsy tests for a biomarker of PD-L1, a protein and targets a type of immunotherapy called checkpoint inhibitors, which helps the patient's immune system attack and kill cancer cells.

full article...